PEDIATRIA |
|
Zaytseva O.V., Tolstova E.M., Zaitseva N.S., Lokshina E.E., Abaseeva T.Yu., Bagirova N.I., Bardenikova S.I., Besedina M.V., Bogdanova N.A., Kuznetsov G.B., Mstislavskaya S.A., Ostroukhova I.P., Rychkova T.I., Serebrovskaya N.B., Striga E.V., Shavlokhova L.A., Shiro- nina N.V., Nikonova M.A., Kuzina S.R., Efimova E.V., Belyaeva T.Yu.
Epidemiological characteristics of respiratory infections during the last autumn-winter season of the COVID-19 pandemic according to data from a repurposed children’s hospital
|
10-18 |
|
|
Kamalova A.A., Garina G.A., Khanafina M.A., Valeeva I.Kh.
The role of fecal biomarkers in predicting inflammatory bowel diseases
|
20-25 |
|
Ikhsanov S.D., Sergienko D.F.
Intergenic interactions of IL-1β and IL-1RN gene polymorphisms in children with duodenal ulcer and erosive gastroduodenitis
|
26-30 |
|
Uspenskiy Yu.P., Petrov S.V., Fominykh Yu.A., Ivanov S.V., Lykova E.P.
Clinical features of ulcerative colitis and Crohn’s disease in St. Petersburg: experience of the city inflammatory bowel disease center
|
32-40 |
|
Shatalova N.A., Mirzaev K.B., Abdullaev Sh.P., Sozaeva Zh.A., Bochkov P.O., Asoskova A.V., Denisenko N.P., Kochetkov A.I., Ebzeeva E.Yu., Chernyaeva M.S., Shastina V.R., Ostroumova O.D., Sychev D.A.
On the possible relationship between the presence of polymorphic variants of CYP3A4/5 cytochrome genes, their metabolic activity with rivaroxaban pharmacokinetics and the development of bleeding in patients with non-valvular atrial fibrillation and chronic kidney disease
|
41-50 |
|
Ostroumova O.D., Telkova S.S., Dzamihov K.K., Kochetkov A.I., Baronov S.A.
Arterial hypertension and cognitive impairment in elderly and senile patients: basic approaches to patient management
|
52-61 |
|
Leonova M.V.
Polypills in the fight against cardiovascular diseases: a modern review of effectiveness
|
62-69 |
|
Izmozherova N.V., Grenaderova M.A., Shambatov M.A., Popov A.A., Kudryavtseva E.V., Bortnik A.E., Vishneva K.A., Shamilov M.D.
The use of angiotensin II type 1 receptor antagonists in the treatment of chronic heart failure against the background of the renin-angiotensin-aldosterone system genetic polymorphisms
|
70-77 |
|
Orlova I.Yu., Batyukina S.V., Kochetkov A.I., Piksina G.F., Plotnikova N.A., Ostroumova O.D.
State of cognitive functions in patients with various forms of atrial fibrillation
|
78-84 |
|
Shuvalova A.S., Prokofieva T.V., Polunina O.S., Polunina E.A.
Association of N-terminal pro C-type natriuretic peptide and endothelin-1 levels with the risk of cardiovascular complications in arterial hypertension six months after COVID-19
|
85-90 |
|
Trukhan D.I., Sulimov A.F., Trukhan L.Yu.
Orofacial pain as a manifestation of myocardial ischemia
|
91-94 |
|
Trofimenko I.N., Chernyak B.A.
Modern possibilities of bronchodilation therapy for patients with chronic obstructive pulmonary disease
|
95-102 |
|
Kostina E.M., Trushina E.Yu., Tipikin V.A., Orlova E.A.
Phenotype of bronchial asthma with fixed obstruction
|
103-107 |
|
Trushina E.Yu., Kostina E.M., Tipikin V.A., Orlova E.A.
Triple therapy in the treatment of patients with a combination of chronic obstructive pulmonary disease and bronchial asthma
|
108-112 |
|
Romanovskikh A.G., Belotserkovskaya Yu.G., Smirnov I.P., Klyachkina I.L.
Modern possibilities of combined pharmacotherapy for cough
|
113-119 |
|
Babanov S.A., Ostryakova N.A., Strizhakov L.A., Melentyev A.V., Lysova M.V.
Determinants of development, prediction and prevention of professional burnout in nurses during the COVID-19 pandemic
|
120-129 |
|
Antonova A.A., Davydova O.V., Davydov M.V., Perova N.Yu., Belyakova I.S., Salikhova M.R., Urudzheva D.Ya.
Public awareness of the use of antibiotics: results of a cross-sectional study (questionnaire survey)
|
130-133 |
|
Mordyk A.V., Romanova M.A., Shapran A.A., Bagisheva N.V., Moiseeva M.V.
Experience of using tubercular recombinant allergen in examination of school-age children living in rural areas
|
134-140 |
|
Trukhan D.I., Rozhkova M.Yu., Ivanova D.S., Goloshubina V.V.
Cold season: the potential of vitamin-mineral complexes in the prevention and treatment of acute respiratory viral infections
|
142-152 |
|
Belskaya G.N., Lukashevich I.G.
Features of management of a patient with secondary progressive multiple sclerosis: a clinical case
|
154-158 |
|
Shiroky R.V., Zakaryaeva A.R., Murtazalieva D.M., Zolotov M.A., Yakovlev M.Yu., Kvitivadze N.G., Parfenov I.P., Fomin V.S.
VR-IC (virtual reality in intensive care) clinical trial protocol: a program for the prevention of delirium and complications of long-term ICU patients using virtual reality
|
160-163 |
|
Azimova Yu.E., Skorobogatykh K.V., Osipova V.V., Korobkova D.Z., Mamkhegov E.Z., Galanina A.S., Guziy E.A., Frolova A.V.
Erenumab – an antimigraine drug: experience of use
|
164-168 |
|
Vorob’eva O.V.
Correction of cognitive impairment associated with age-dependent cerebral microangiopathy after COVID-19 using the combination drug vinpocetine+piracetam: clinical case report
|
169-173 |
|
Sobolev A.V., Ponomarenko G.N., Grigoriev S.G.
Medical and psychological rehabilitation of patients with functional asthenia: determinants of effectiveness
|
174-177 |
DERMATOLOGY / ALLERGOLOGY |
|
Perlamutrov Yu.N., Olkhovskaya K.B., Lyapon A.O.
Clinical effectiveness of early use of systemic antibacterial therapy for acne
|
178-182 |
|
Kandrashkina Yu.A., Orlova E.A., Levashova O.A., Kostina E.M.
Filaggrin as a biomarker of exacerbation of atopic dermatitis during pregnancy
|
183-187 |
|
Novikov A.I., Novikov Yu.A., Zubareva E.Yu., Okhlopkov V.A.
A case of pseudoxanthoma elasticus in a young woman
|
188-191 |
MEDICAL MANAGEMENT |
|
Milovanov S.S.
Clinical center type in predicting patient enrollment
|
192-196 |
UROLOGY / NEPHROLOGY |
|
Sinyakova L.A., Kosova I.V., Loran O.B., Barsegian V.A.
Guideline on acute cystitis (uncomplicated urinary tract infection) (ICD-10 code N30.0) for general practitioners
|
198-206 |
|
Sturov N.V., Popov S.V., Mikhailov A.A., Zhukov V.A.
Disturbance of the gut microbiota and its correction in patients with chronic prostatitis
|
208-213 |
Oncology |
|
Bakhidze E.V., Belyaeva A.V., Berlev I.V.
New approaches to staging and treatment of primary endometrial cancer
|
214-220 |
Русский
